Register of Epoch-Making Biologics Hits 10 Years

The BSRBR is funded by a grant from the BSR. The BSR receives funding from Abbott Laboratories, Biovitrum/SOBI, Merck Sharp & Dohme, Pfizer, Roche, and UCB. This income finances a separate contract between the BSR and the University of Manchester that runs the BSRBR. All decisions concerning data analysis, interpretation, and publications are made autonomously of any industrial contribution. Dr. Isenberg and Dr. Symmons declared that they had no personal conflicts of interest. Dr. Zink has received research grants from Abbott, Amgen, Bristol-Myers Squibb, Essex Pharma, Pfizer, Roche, and UCB.